1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with DDPAC in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martens, LH | 1 |
| Zhang, J | 1 |
| Barmada, SJ | 1 |
| Zhou, P | 1 |
| Kamiya, S | 1 |
| Sun, B | 1 |
| Min, SW | 1 |
| Gan, L | 1 |
| Finkbeiner, S | 1 |
| Huang, EJ | 1 |
| Farese, RV | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and DDPAC
| Article | Year |
|---|---|
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Cells, Cultured; Cerebral Cortex; | 2012 |